Search Medical Condition
Please enter condition
Please choose location from dropdown

Cooper City, Florida Clinical Trials

A listing of Cooper City, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (551) clinical trials

Combination Chemotherapy Bevacizumab and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer

PRIMARY OBJECTIVES: I. To determine the efficacy, based on progression-free survival (PFS), of fluorouracil, oxaliplatin, and leucovorin calcium (mFOLFOX6)/bevacizumab plus atezolizumab (combination) and atezolizumab (single agent) as compared to mFOLFOX6/bevacizumab (control). SECONDARY OBJECTIVES: I. To compare the overall survival. II. To compare the objective response rates (ORR) per Response Evaluation ...

Phase

9.61 miles

Learn More »

Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission

The purpose of this study is to explore the effects of early intensive antiretroviral therapy (ART) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among HIV-infected infants. The study will enroll two cohorts. Cohort 1 will include infants at high risk for in utero ...

Phase

9.61 miles

Learn More »

Paclitaxel Trastuzumab and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast Cancer

PRIMARY OBJECTIVES: I. To determine whether the addition of atezolizumab to a regimen of paclitaxel, pertuzumab, and trastuzumab will improve the progression-free survival (PFS), as assessed by investigator using Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria, relative to a regimen of paclitaxel, pertuzumab, trastuzumab, and placebo in patients ...

Phase

9.61 miles

Learn More »

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

This study will confirm the dose and evaluate the safety, acceptability, tolerability, and pharmacokinetics (PK) of oral cabotegravir (CAB), long-acting injectable cabotegravir (CAB LA), and long-acting injectable rilpivirine (RPV LA) in virologically suppressed HIV1 infected children and adolescents aged 12 to less than 18 years. The study will include two ...

Phase

9.61 miles

Learn More »

Tenofovir Alafenamide in Preventing Liver Complications in Participants With Current or Past Hepatitis B Virus Who Are Receiving Anti-Cancer Therapy for Solid Tumors

PRIMARY OBJECTIVES: I. To compare the effect of prophylactic tenofovir alafenamide (TAF) therapy versus upon indication TAF therapy on time-to-adverse liver outcomes of liver failure or liver-related death in patients with chronic HBV infection (hepatitis B surface antigen positive [HBsAg+] and antibody to hepatitis B core antigen positive [anti-HBc+]) receiving ...

Phase

9.61 miles

Learn More »

To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.

This is a prospective, open label, randomised, multi-centre Phase 2 study that will assess the efficacy and safety of olaparib monotherapy versus olaparib in combination with an inhibitor of ATR (AZD6738) and olaparib monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib) in second or third line setting ...

Phase

9.61 miles

Learn More »

Are you also taking Metformin? If yes, you may be eligible for a clinical research study testing an investigational insulin for diabetes. If you meet the study criteria you will receive study related care from a team of doctors and nurses, and study drug at no cost. Reimbursement for time ...

Phase

9.61 miles

Learn More »

Are you a Diabetic taking Metformin? Are you also taking other diabetic oral medications? If yes, you may be eligible for a clinical research study testing an investigational medication for diabetes. If you meet the study criteria you will receive study related care from a team of doctors and nurses, ...

Phase

9.61 miles

Learn More »

If you have uterine fibroids that are causing heavy monthly bleeding, you may be eligible to partcipipate in our medical research study of a new treatment. Qualified study participants will receive study-related care and treatment at no cost, as well as compensation for time and travel expenses. Contact M&O Clinical ...

Phase

9.61 miles

Learn More »

Safety Pharmacokinetics and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Adults

This study has 2 parts: Part A (Cohorts 1-5) and Part B (Cohorts 6-8). The primary objectives of this study are: Part A: To evaluate the short-term antiviral activity of GS-6207 compared to placebo in HIV-1 infected adults who are antiretroviral treatment naive or are experienced but capsid inhibitor (CAI) ...

Phase

9.61 miles

Learn More »